These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 9574520)

  • 21. The CD8 isoform CD8alphaalpha is not a functional homologue of the TCR co-receptor CD8alphabeta.
    Gangadharan D; Cheroutre H
    Curr Opin Immunol; 2004 Jun; 16(3):264-70. PubMed ID: 15134773
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Inhibition of T-cell activation by an anti-human class I MHC reactive monoclonal antibody occurs at a point distal to TCR-CD3 mediated signal transduction.
    Smith DM; Bluestone JA; Thistlethwaite JR; Woodle ES
    Transplant Proc; 1995 Feb; 27(1):395-7. PubMed ID: 7879035
    [No Abstract]   [Full Text] [Related]  

  • 23. CD4+ T cells mature in the absence of MHC class I and class II expression in Ly-6A.2 transgenic mice.
    Henderson SC; Berezovskaya A; English A; Palliser D; Rock KL; Bamezai A
    J Immunol; 1998 Jul; 161(1):175-82. PubMed ID: 9647222
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Coreceptor function of CD4 in response to MHC class I molecule].
    Zvezdova ES; Grinenko TS; Pobezinskaia EL; Pobezinskiĭ LA; Kazanskiĭ DB
    Mol Biol (Mosk); 2008; 42(4):662-72. PubMed ID: 18856067
    [TBL] [Abstract][Full Text] [Related]  

  • 25. CD8alpha+beta(low) effector T cells in systemic lupus erythematosus.
    Werwitzke S; Tiede A; Jacobs R; Zielinska-Skowronek M; Buyny S; Schmidt RE; Witte T
    Scand J Immunol; 2008 May; 67(5):501-8. PubMed ID: 18405327
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Redirecting human CD4+ T lymphocytes to the MHC class I-restricted melanoma antigen MAGE-A1 by TCR alphabeta gene transfer requires CD8alpha.
    Willemsen R; Ronteltap C; Heuveling M; Debets R; Bolhuis R
    Gene Ther; 2005 Jan; 12(2):140-6. PubMed ID: 15496961
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Low binding capacity of murine tetramers mutated at residue 227 does not preclude the ability to efficiently activate CD8+ T lymphocytes.
    Nugent CT; Renteria RO; Kuus-Reichel K; Kumar A
    Immunol Lett; 2005 May; 98(2):208-15. PubMed ID: 15860220
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Galectin-1 specifically modulates TCR signals to enhance TCR apoptosis but inhibit IL-2 production and proliferation.
    Vespa GN; Lewis LA; Kozak KR; Moran M; Nguyen JT; Baum LG; Miceli MC
    J Immunol; 1999 Jan; 162(2):799-806. PubMed ID: 9916701
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Molecular modelling of co-receptor CD8 alpha alpha and its complex with MHC class I and T-cell receptor in sea bream (Sparus aurata).
    Costantini S; Buonocore F; Facchiano AM
    Fish Shellfish Immunol; 2008 Dec; 25(6):782-90. PubMed ID: 18951040
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Immune selection in murine tumors. Ph.d thesis.
    Svane IM; Engel AM
    APMIS Suppl; 2003; (106):1-46. PubMed ID: 12739251
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The orientation and nature of the interaction between beef insulin-specific TCRs and the insulin/class II MHC complex.
    Wither JE; Vukusic B
    J Immunol; 1999 Feb; 162(4):2113-22. PubMed ID: 9973485
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The marsupial CD8 gene locus: molecular cloning and expression analysis of the alpha and beta sequences in the gray short-tailed opossum (Monodelphis domestica) and the tammar wallaby (Macropus eugenii).
    Duncan LG; Nair SV; Deane EM
    Vet Immunol Immunopathol; 2009 May; 129(1-2):14-27. PubMed ID: 19135263
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cutting edge: MHC class I triggering by a novel cell surface ligand costimulates proliferation of activated human T cells.
    Agrawal S; Marquet J; Freeman GJ; Tawab A; Bouteiller PL; Roth P; Bolton W; Ogg G; Boumsell L; Bensussan A
    J Immunol; 1999 Feb; 162(3):1223-6. PubMed ID: 9973372
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Antagonism of cytotoxic T-lymphocyte activation by soluble CD8.
    Sewell AK; Gerth UC; Price DA; Purbhoo MA; Boulter JM; Gao GF; Bell JI; Phillips RE; Jakobsen BK
    Nat Med; 1999 Apr; 5(4):399-404. PubMed ID: 10202928
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A CD8 DE loop peptide analog prevents graft-versus-host disease in a multiple minor histocompatibility antigen-mismatched bone marrow transplantation model.
    Choksi S; Kim JC; Whitaker-Menezes D; Murphy GF; Friedman TM; Korngold R
    Biol Blood Marrow Transplant; 2004 Oct; 10(10):669-80. PubMed ID: 15389433
    [TBL] [Abstract][Full Text] [Related]  

  • 36. IL-2 down-regulates the expression of TCR and TCR-associated surface molecules on CD8(+) T cells.
    Kambayashi T; Assarsson E; Chambers BJ; Ljunggren HG
    Eur J Immunol; 2001 Nov; 31(11):3248-54. PubMed ID: 11745341
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Role of CD8beta domains in CD8 coreceptor function: importance for MHC I binding, signaling, and positive selection of CD8+ T cells in the thymus.
    Bosselut R; Kubo S; Guinter T; Kopacz JL; Altman JD; Feigenbaum L; Singer A
    Immunity; 2000 Apr; 12(4):409-18. PubMed ID: 10795739
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Mapping the binding site on CD8 beta for MHC class I reveals mutants with enhanced binding.
    Devine L; Thakral D; Nag S; Dobbins J; Hodsdon ME; Kavathas PB
    J Immunol; 2006 Sep; 177(6):3930-8. PubMed ID: 16951356
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Chimeric beta2 microglobulin/CD3zeta polypeptides expressed in T cells convert MHC class I peptide ligands into T cell activation receptors: a potential tool for specific targeting of pathogenic CD8(+) T cells.
    Margalit A; Fishman S; Berko D; Engberg J; Gross G
    Int Immunol; 2003 Nov; 15(11):1379-87. PubMed ID: 14565936
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The MHC class II ligand lymphocyte activation gene-3 is co-distributed with CD8 and CD3-TCR molecules after their engagement by mAb or peptide-MHC class I complexes.
    Hannier S; Triebel F
    Int Immunol; 1999 Nov; 11(11):1745-52. PubMed ID: 10545478
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.